@Bear10 you continue to report that the FDA submission has not...

@Bear10 you continue to report that the FDA submission has not gone through or failed, what basis do you have in making this claim, aside from voicing previous staff's concerns, who were responsible for the FDA submission and had oversight of the process in the first place?!?

Unless you can substantiate your claim that the FDA submission has failed, in which the company is required to inform shareholders, why try and preempt the formal decision that is yet to be determined?

I believe that you are also falsely claiming or Peta is, in regards to the business not spending any money on legal fees in regards to her exit of the business. She is well aware of the business engaging legal representation in regards to mediation of her concerns and exiting of the business. Also since resigning, she would have no oversight in the business as to what the total legal expenditure was being applied to.

It is absurd to think that the legal fees were either spent on Jack or Jack and Peta exclusively. We are well aware that a number of staff have either chosen to or have been let go by the business. This would require a level of legal engagement, as to the 249 D, which we will no doubt see a level of cost this quarter.

I completely agree that the business and the board need to explain to shareholders at the up coming AGM as to their justification for spending these funds as we feel that they are not giving shareholders, their support and funding, the respect they deserve.

A couple of quick thoughts in regards to the letter to medibio shareholders. This was certainly a good chance for the group who lodged the 249D to provide further information around their concerns and more importantly provide shareholders with credible information around their Board candidates and why shareholders should consider voting them in. Unfortunately, there was a complete lack of information around the potential Board candidates, their experience and value they can bring to the company. Shareholders are left to consider their voting on the 'hope' that this new group can solve the issues we are experiencing and faced with.

I personally do not have an issue with the appointment of a senior executive in the business that is related to a major shareholder, as I believe her experience and resume is more than suitable to warrant her appointment. To be honest I thin we were lucky to find someone on short notice to fill that role. I think the reference in the letter is unjustified and is praying on the ill informed shareholder. If they have valid concerns around this appointment, raise them, just to state that she is related and that's a concern, is not enough.

Consideration of a debt facility comes with both significant positives and serious negative scenarios for a business that does not have the luxury to service or repay the facility from near term cash flows. Whilst we would all like to hope for the best outcome, should a debt facility be in place, the reality is, should things not play out operationally for the business over the term of the facility, the company would be extremely limited in its ability to repay the debt, without handing over majority control of the company to the providers of this proposed facility. Don't get me wrong iam all for looking at ways to reduce dilution when it comes time to raise capital, however people need to appreciate that each scenario comes with a range of + & -, none of which is a silver bullet for the company.

I am certainly looking for accountability to be taken at the AGM and whilst I believe in seeing change at the Board level with the view to bring on board a more appropriate skill set that would benefit the business at the current juncture. I personally am not interested in seeing mass disruption at the Board level, by potentially seeing the rest of the Board exit as a result of this process. We need stability in the business and I believe through engagement with the Board and Chairman we can see effective change take place the right way.

Iam encouraged by the new CEO appointment and look forward to speaking with and meeting him soon.